Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02081573 · ClinicalTrials.gov registry record · NA

Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study

A NA study of Diabetes Mellitus, Type 2, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02081573 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by University of Pittsburgh. The registered enrollment target is 10 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02081573, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Primary aim: examine feasibility and acceptability of a brief cognitive therapy protocol for type II diabetes administered by nurse care managers or health coaches via phone.

Conditions Studied

Interventions

  • BEHAVIORAL Brief CBT

Study Locations (1)

Pennsylvania

  • University of Pittsburgh School of Nursing - Pittsburgh

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-01
Est. Completion 2016-07
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02081573

The ClinicalTrials.gov registry entry for NCT02081573 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (100% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Brief CBT is the first listed.

NCT02081573 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02081573 about?

NCT02081573 is a clinical study titled "Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study". Primary aim: examine feasibility and acceptability of a brief cognitive therapy protocol for type II diabetes administered by nurse care managers or health coaches via phone.

What is the current status of trial NCT02081573?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-01. Estimated completion is 2016-07.

What conditions does trial NCT02081573 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT02081573?

The interventions under investigation include: Brief CBT (BEHAVIORAL).

Who is sponsoring clinical trial NCT02081573?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02081573 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.